Position in GRAL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,303,338
+$9,790,903 QoQ
Shares Held
199,368
+498.0% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NATIXIS holds $131,242,925 across 14 Diagnostics & Research names. GRAL ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
212,832 | $40,352,947 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
66,593 | $32,732,457 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
12,592 | $15,881,030 | |
| 4 | GRAL |
GRAIL, Inc.
This page
|
199,368 | $10,303,338 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
18,018 | $10,124,134 | |
| 6 | DGX |
Quest Diagnostics Inc
|
28,191 | $5,524,872 | |
| 7 | WAT |
Waters Corp /De/
|
16,488 | $4,910,126 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
7,948 | $3,816,550 |
All Filings in GRAL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,303,338 | 199,368 | Shares | Sole | 2026-05-14 | |
| 2024-06-30 | $512,435 | 33,340 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||